143 related articles for article (PubMed ID: 2234853)
1. Macular dystrophy of the cornea. A systemic disorder of keratan sulfate metabolism.
Edward DP; Thonar EJ; Srinivasan M; Yue BJ; Tso MO
Ophthalmology; 1990 Sep; 97(9):1194-200. PubMed ID: 2234853
[TBL] [Abstract][Full Text] [Related]
2. Macular corneal dystrophy in Iceland. A clinical, genealogic, and immunohistochemical study of 28 patients.
Jonasson F; Oshima E; Thonar EJ; Smith CF; Johannsson JH; Klintworth GK
Ophthalmology; 1996 Jul; 103(7):1111-7. PubMed ID: 8684802
[TBL] [Abstract][Full Text] [Related]
3. Macular corneal dystrophy. Lack of keratan sulfate in serum and cornea.
Klintworth GK; Meyer R; Dennis R; Hewitt AT; Stock EL; Lenz ME; Hassell JR; Stark WJ; Kuettner KE; Thonar EJ
Ophthalmic Paediatr Genet; 1986 Dec; 7(3):139-43. PubMed ID: 2951638
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural localization of sulfated and unsulfated keratan sulfate in normal and macular corneal dystrophy type I.
Lewis D; Davies Y; Nieduszynski IA; Lawrence F; Quantock AJ; Bonshek R; Fullwood NJ
Glycobiology; 2000 Mar; 10(3):305-12. PubMed ID: 10704529
[TBL] [Abstract][Full Text] [Related]
5. Recurrent macular corneal dystrophy type II 49 years after penetrating keratoplasty.
Küchle M; Cursiefen C; Fischer DC; Schlötzer-Schrehardt U; Naumann GO
Arch Ophthalmol; 1999 Apr; 117(4):528-31. PubMed ID: 10206585
[TBL] [Abstract][Full Text] [Related]
6. Macular corneal dystrophy. Studies of sulfated glycosaminoglycans in corneal explant and confluent stromal cell cultures.
Klintworth GK; Smith CF
Am J Pathol; 1977 Oct; 89(1):167-82. PubMed ID: 143892
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical classification of primary and recurrent macular corneal dystrophy in Germany: subclassification of immunophenotype I A using a novel keratan sulfate antibody.
Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Haubeck HD; Küchle M; Naumann GO
Exp Eye Res; 2001 Nov; 73(5):593-600. PubMed ID: 11747360
[TBL] [Abstract][Full Text] [Related]
8. [Immunophenotype classification of macular corneal dystrophy: first case report of immunophenotype I A outside of Saudi Arabia. A clinical histopathological correlation with immunohistochemistry and electron microscopy].
Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Küchle M
Klin Monbl Augenheilkd; 2000 Aug; 217(2):118-26. PubMed ID: 11022667
[TBL] [Abstract][Full Text] [Related]
9. Differential immunogold localisation of sulphated and unsulphated keratan sulphate proteoglycans in normal and macular dystrophy cornea using sulphation motif-specific antibodies.
Young RD; Akama TO; Liskova P; Ebenezer ND; Allan B; Kerr B; Caterson B; Fukuda MN; Quantock AJ
Histochem Cell Biol; 2007 Jan; 127(1):115-20. PubMed ID: 16944190
[TBL] [Abstract][Full Text] [Related]
10. Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype.
Klintworth GK; Oshima E; al-Rajhi A; al-Saif A; Thonar EJ; Karcioglu ZA
Am J Ophthalmol; 1997 Jul; 124(1):9-18. PubMed ID: 9222226
[TBL] [Abstract][Full Text] [Related]
11. Measurement of activities of human serum sulfotransferases which transfer sulfate to the galactose residues of keratan sulfate and to the nonreducing end N-acetylglucosamine residues of N-acetyllactosamine trisaccharide: comparison between normal controls and patients with macular corneal dystrophy.
Hasegawa N; Torii T; Nagaoka I; Nakayasu K; Miyajima H; Habuchi O
J Biochem; 1999 Feb; 125(2):245-52. PubMed ID: 9990120
[TBL] [Abstract][Full Text] [Related]
12. Macular corneal dystrophy type II: multiple studies on a cornea with low levels of sulphated keratan sulphate.
Quantock AJ; Fullwood NJ; Thonar EJ; Waltman SR; Capel MS; Ito M; Verity SM; Schanzlin DJ
Eye (Lond); 1997; 11 ( Pt 1)():57-67. PubMed ID: 9246278
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypes of macular corneal dystrophy in India and correlation with mutations in CHST6.
Sultana A; Klintworth GK; Thonar EJ; Vemuganti GK; Kannabiran C
Mol Vis; 2009; 15():319-25. PubMed ID: 19204788
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel mutations in the carbohydrate sulfotransferase gene (CHST6) causing macular corneal dystrophy.
El-Ashry MF; Abd El-Aziz MM; Wilkins S; Cheetham ME; Wilkie SE; Hardcastle AJ; Halford S; Bayoumi AY; Ficker LA; Tuft S; Bhattacharya SS; Ebenezer ND
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):377-82. PubMed ID: 11818380
[TBL] [Abstract][Full Text] [Related]
15. Macular corneal dystrophy: reduction in both corneal thickness and collagen interfibrillar spacing.
Quantock AJ; Meek KM; Ridgway AE; Bron AJ; Thonar EJ
Curr Eye Res; 1990 Apr; 9(4):393-8. PubMed ID: 2340750
[TBL] [Abstract][Full Text] [Related]
16. Decreased GlcNAc 6-O-sulfotransferase activity in the cornea with macular corneal dystrophy.
Hasegawa N; Torii T; Kato T; Miyajima H; Furuhata A; Nakayasu K; Kanai A; Habuchi O
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3670-7. PubMed ID: 11053262
[TBL] [Abstract][Full Text] [Related]
17. Altered fine structures of corneal and skeletal keratan sulfate and chondroitin/dermatan sulfate in macular corneal dystrophy.
Plaas AH; West LA; Thonar EJ; Karcioglu ZA; Smith CJ; Klintworth GK; Hascall VC
J Biol Chem; 2001 Oct; 276(43):39788-96. PubMed ID: 11514545
[TBL] [Abstract][Full Text] [Related]
18. Keratan sulphate in the trabecular meshwork and cornea.
Davies Y; Fullwood NJ; Marcyniuk B; Bonshek R; Tullo A; Nieduszynski IA
Curr Eye Res; 1997 Jul; 16(7):677-86. PubMed ID: 9222085
[TBL] [Abstract][Full Text] [Related]
19. Localization and expression of CHST6 and keratan sulfate proteoglycans in the human cornea.
Di Iorio E; Barbaro V; Volpi N; Bertolin M; Ferrari B; Fasolo A; Arnaldi R; Brusini P; Prosdocimo G; Ponzin D; Ferrari S
Exp Eye Res; 2010 Aug; 91(2):293-9. PubMed ID: 20537995
[TBL] [Abstract][Full Text] [Related]
20. Absence of normal keratan sulfate in the blood of patients with macular corneal dystrophy.
Thonar EJ; Meyer RF; Dennis RF; Lenz ME; Maldonado B; Hassell JR; Hewitt AT; Stark WJ; Stock EL; Kuettner KE
Am J Ophthalmol; 1986 Nov; 102(5):561-9. PubMed ID: 2946233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
